Roche Holding AG (RHHBY)
OTCMKTS: RHHBY · Delayed Price · USD
39.27
-0.05 (-0.13%)
Jul 19, 2024, 3:59 PM EDT - Market closed

Roche Holding AG Income Statement

Millions CHF. Fiscal year is Jan - Dec.
Year Ending
TTM Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020
Revenue
-60,44165,81462,80158,323
Revenue Growth (YoY)
--8.16%4.80%7.68%-
Cost of Revenue
-16,35719,73719,64716,177
Gross Profit
-44,08446,07743,15442,146
Selling, General & Admin
-14,88114,20113,24912,614
Research & Development
-14,20015,22514,79913,009
Other Operating Expenses
--392-825-3,049-2,020
Operating Expenses
-28,68928,60124,99923,603
Operating Income
-15,39517,47618,15518,543
Interest Income
-19567-16
Interest Expense
-997690419553
Pretax Income
-14,07916,32717,39817,965
Income Tax
-1,7212,7962,4632,897
Net Income
-12,35813,53114,93515,068
Net Income Growth
--8.67%-9.40%-0.88%-
Shares Outstanding (Basic)
--5,6946,0506,086
Shares Outstanding (Diluted)
--5,6946,0506,086
Shares Change
---5.88%-0.58%-
EPS (Basic)
--1.942.052.09
EPS (Diluted)
--1.922.022.06
EPS Growth
---5.12%-1.94%-
Free Cash Flow
-11,44613,25116,42711,876
Free Cash Flow Per Share
--2.332.721.95
Gross Margin
-72.94%70.01%68.72%72.26%
Operating Margin
-25.47%26.55%28.91%31.79%
Profit Margin
-20.45%20.56%23.78%25.84%
Free Cash Flow Margin
-18.94%20.13%26.16%20.36%
Effective Tax Rate
-12.22%17.13%14.16%16.13%
EBITDA
-18,65721,52622,86222,501
EBITDA Margin
-30.87%32.71%36.40%38.58%
EBIT
-14,88116,95017,81718,502
EBIT Margin
-24.62%25.75%28.37%31.72%